Genomic Vision is a leading brand that is driving advances in precision genomics to accelerate the identification and bioproduction of advanced cell and gene therapies. With a focus on safety and precision, Genomic Vision offers a range of high-quality genomic solutions to improve quality control and bioproduction standards of advanced gene therapies at scale. With a strong leadership team and an experienced Board guiding their efforts, Genomic Vision is well-positioned to meet the increasing demand for sophisticated and targeted advanced therapies.

Their cutting-edge technology, products, and services provide highly accurate, fast, and accessible solutions for genome characterization, enabling the full potential of advanced therapies to be unlocked and improve the lives of patients worldwide. As a listed company on the regulated market of Euronext in Paris under the symbol GV, Genomic Vision is dedicated to delivering innovative solutions and partnering with customers to revolutionize the field of precision genomics. Trust their expertise and experience to drive advancements in the field of genomics and revolutionize the future of advanced cell and gene therapies